BlackRock Fund Advisors’s Amicus Therapeutics FOLD Stock Holding History

BlackRock Fund Advisors’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$37.7M	Buy	7,585,493 +950,800	+14%	+$6.58M	0.01%	1843
2016 Q3	$49.1M	Buy	6,634,693 +849,379	+15%	+$5.74M	0.01%	1595
2016 Q2	$31.6M	Buy	5,785,314 +340,915	+6%	+$2.38M	0.01%	1775
2016 Q1	$46M	Buy	5,444,399 +83,654	+2%	+$592K	0.01%	1499
2015 Q4	$52M	Buy	5,360,745 +137,544	+3%	+$1.24M	0.01%	1443
2015 Q3	$73.1M	Buy	5,223,201 +1,672,839	+47%	+$26.2M	0.02%	1157
2015 Q2	$50.2M	Buy	3,550,362 +2,191,189	+161%	+$26.3M	0.01%	1521
2015 Q1	$14.8M	Buy	1,359,173 +97,795	+8%	+$862K	﹤0.01%	2226
2014 Q4	$10.5M	Buy	1,261,378 +1,134,479	+894%	+$7.79M	﹤0.01%	2436
2014 Q3	$755K	Buy	126,899 +37,238	+42%	+$195K	﹤0.01%	3204
2014 Q2	$299K	Sell	89,661 -764,978	-90%	-$1.8M	﹤0.01%	3343
2014 Q1	$1.77M	Buy	854,639 +24,550	+3%	+$61.4K	﹤0.01%	3150
2013 Q4	$1.95M	Sell	830,089 -582,014	-41%	-$1.28M	﹤0.01%	3144
2013 Q3	$3.28M	Buy	1,412,103 +186,444	+15%	+$468K	﹤0.01%	3018
2013 Q2	$2.86M	Buy	+1,225,659	New	+$3.77M	﹤0.01%	3012

Other funds holding FOLD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

BlackRock Fund Advisors's FOLD Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Amicus Therapeutics (FOLD) stake by 14% in Q4 2016, buying an estimated $6.58M and bringing the position to 7,585,493 shares worth $37.7M. The position accounts for 0.01% of the portfolio, ranked #1843.

BlackRock Fund Advisors first reported a position in FOLD in Q2 2013 and has held it in 15 quarters since. The position peaked at $73.1M in Q3 2015. 135 funds tracked by Wall St. Rank hold FOLD as of Q4 2016.

BlackRock Fund Advisors held 7,585,493 shares of Amicus Therapeutics worth $37.7M as of Q4 2016.
BlackRock Fund Advisors bought 950,800 Amicus Therapeutics shares in Q4 2016, an estimated $6.58M.
Amicus Therapeutics made up 0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #1843 holding.
BlackRock Fund Advisors first reported a position in Amicus Therapeutics in Q2 2013 and has held it in 15 quarters since.
BlackRock Fund Advisors's Amicus Therapeutics position peaked at $73.1M in Q3 2015.
135 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.